Evofem Biosciences Inc 2026年季度报告

FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromto Commission File Number: 001-36754 Registrant’s telephone number, including area code: (858) 550-1900 N/A(Former name or former address, if changed since last report.) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities ExchangeAct of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has beensubject to such filing requirements for the past 90 days. Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required tosubmit such files). Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reportingcompany, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and“emerging growth company” in Rule 12b-2 of the Exchange Act. Accelerated filer☐Smaller reporting company☒Emerging growth company☐ Large accelerated filer☐ Non-accelerated filer☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complyingwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☒ The number of shares of the registrant’s Common Stock, $0.0001 par value per share, outstanding as of May 11, 2026 was 132,530,081. Table of Contents PageFORWARD-LOOKING STATEMENTS1PART I.FINANCIAL INFORMATIONItem 1.Financial Statements (Unaudited)3Condensed Consolidated Balance Sheets3Condensed Consolidated Statements of Operations4Condensed Consolidated Statements of Comprehensive Operations5Condensed Consolidated Statements of Convertible and Redeemable Preferred Stock and Stockholders’ Deficit6Condensed Consolidated Statements of Cash Flows7Notes to Unaudited Condensed Consolidated Financial Statements8Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations41Item 3.Quantitative and Qualitative Disclosures About Market Risk50Item 4.Controls and Procedures50PART II.OTHER INFORMATIONItem 1.Legal Proceedings52Item 1A.Risk Factors52Item 2.Unregistered Sales of Equity Securities and Use of Proceeds52Item 3.Defaults Upon Senior Securities52Item 4.Mine Safety Disclosures52Item 5.Other Information52Item 6.Exhibits53Signatures54 FORWARD-LOOKING STATEMENTS This quarterly report on Form 10-Q (Quarterly Report), contains forward-looking statements that involve substantial risks anduncertainties. The forward-looking statements are contained principally in the section entitled “Management’s Discussion and Analysis ofFinancial Condition and Results of Operations.” All statements, other than statements of historical facts, contained in this Quarterly Report,including statements regarding our strategy, future operations, future financial position, projected costs, prospects, plans and objectives ofmanagement, are forward-looking statements. Words such as, but not limited to, “anticipate,” “aim,” “believe,” “contemplate,” “continue,”“could,” “design,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “seek,” “should,”“suggest,” “strategy,” “target,” “will,” “would,” and similar expressions or phrases, or the negative of those expressions or phrases, are intendedto identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements include, among other things, statements about: ●our ability to continue as a going concern;●our ability to remediate the material weaknesses in our internal controls and procedures identified by management;●our ability to obtain necessary approvals of any corporate action(s) needing stockholder or other approvals;●our ability to file Annual and Quarterly Reports on a timely basis;●our ability to raise additional capital to fund our operations if and as needed;●our ability to achieve and sustain profitability;●our estimates regarding expenses, revenues, financial performance, and capital requirements, including the length of time our capitalresources will sustain our operations;●the Notices of Default and cancellation of Forbearance Agre